Search

Your search keyword '"Barwell J"' showing total 199 results

Search Constraints

Start Over You searched for: Author "Barwell J" Remove constraint Author: "Barwell J" Search Limiters Full Text Remove constraint Search Limiters: Full Text
199 results on '"Barwell J"'

Search Results

3. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

4. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

5. Patients with Small Abdominal Aortic Aneurysm are at Significant Risk of Cardiovascular Events and this Risk is not Addressed Sufficiently

6. Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes

8. Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants

10. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

13. Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors

14. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

15. Corrigendum to: Cohort profile: Extended Cohort for E-health, Environment and DNA (EXCEED)

23. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

24. Cohort Profile: Extended Cohort for E-health, Environment and DNA (EXCEED)

25. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

27. Comprehensive cancer-predisposition gene testing in an adult multiple primary tumor series shows a broad range of deleterious variants and atypical tumor phenotypes

32. Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1and MSH2missense variants

33. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition (vol 118, pg 266, 2018)

34. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

35. Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls

36. A versatile model of open-fracture infection

37. Report of a Delphi exercise to inform the design of a research programme on screening for thoracic aortic disease.

41. Patients with Small Abdominal Aortic Aneurysm are at Significant Risk of Cardiovascular Events and this Risk is not Addressed Sufficiently

42. Routine cholangiography in the modern era

43. Landscape of familial isolated and young-onset pituitary adenomas: Prospective diagnosis in AIP mutation carriers

44. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

45. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

46. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor:implications for adrenomedullin and calcitonin gene-related peptide pharmacology

47. Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

48. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

49. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

50. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

Catalog

Books, media, physical & digital resources